Fairvalue-Calculator Fairvalue-Calculator
EN DE

Hangzhou Coco Healthcare Products Co (301009) Fair Value & Analysis

Consumer Defensive · CN · Market cap 2.4B CNY

Price¥8.95
Fair Value¥3.56
Upside-60.2%
Quality90/100
Evidence: Medium Range ¥3.05 – ¥4.07

Fair value as of: Jun 24, 2026

Analysis

Hangzhou Coco Healthcare Products Co (301009) currently trades at ¥8.95, while our model-based Fair Value estimate is ¥3.56 — implying the stock looks roughly 60.2% overvalued today. We read business quality at 90/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Hangzhou Coco Healthcare Products Co.,Ltd. engages in the research, development, production, and sale of baby care, adult incontinence, and pet hygiene products in China and internationally. It offers adult incontinence products, including adult diapers, adult pull-up pants, nursing pads, maternity towels, menstrual pants, absorbent towels, and other products, as well as feminine, cleaning, family, and medical care products. The company was formerly known as Hangzhou Qiaozi Paper Industry Co.,Ltd. and changed its name to Hangzhou Coco Healthcare Products Co.,Ltd. in December 2011. Hangzhou Coco Healthcare Products Co.,Ltd. was incorporated in 2001 and is headquartered in Hangzhou, China.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Hangzhou Coco Healthcare Products Co (301009) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥3.56 versus a price of ¥8.95 — about −60% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 301009?
Our 21-model fair value for Hangzhou Coco Healthcare Products Co is ¥3.56 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥8.95.
What is the quality score of 301009?
Hangzhou Coco Healthcare Products Co has a Quality Score of 90/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.